Novartis nears deal to buy U.S. biotech firm Medicines Co for about $7 billion: WSJ
FILE PHOTO: Switzerland’s national flag flies in front of the logo of Swiss drugmaker Novartis in Basel, Switzerland, January 30,…
Novartis to buy U.S. biotech The Medicines Co. for $9.7 billion
ZURICH (Reuters) – Novartis AG (NOVN.S) is buying U.S. biotechnology company The Medicines Co (MDCO.O) for about $9.7 billion, the…
No-deal Brexit could deepen Europe’s shortage of medicines – experts
BRUSSELS (Reuters) – As the Oct. 31 deadline for Britain to leave the European Union approaches, health professionals are warning…
WHO keeps key lung cancer drugs off its essential medicines list
GENEVA/ZURICH (Reuters) – Immunotherapies that have emerged as a breakthrough in treating lung cancer have been rejected for inclusion on…